Skip to content

Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease

Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01392365
Enrollment
117
Registered
2011-07-12
Start date
2011-07-31
Completion date
2015-02-28
Last updated
2016-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Intestinal Tuberculosis

Keywords

Crohn's disease, Intestinal tuberculosis, Diagnosis, Differential

Brief summary

The aim of this study is to develop a scoring system and a prediction model for differential diagnosis between intestinal tuberculosis and Crohn's disease.

Detailed description

Crohn's disease and intestinal tuberculosis mimic each other in clinical, endoscopic, and histological features. In addition, the yield of microbiological/histological test (AFB stain, caseating granuloma) is not high in clinical setting. Therefore, distinguishing CD from ITB especially in highly endemic areas for TB is challenging. The aim of this study is to develop and to validate a scoring system and a prediction model for differential diagnosis between intestinal tuberculosis and Crohn's disease

Interventions

None listed

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Final diagnostic criteria: * Crohn' disease (at least two of the following is met) 1. Clinical history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding 2. Endoscopic findings of mucosal cobblestoning, linear ulceration, skip areas, or perianal disease 3. Radiologic findings of stricture, fistula, mucosal cobblestoning, or ulceration 4. Macroscopic appearance of bowel-wall induration, mesenteric lymphadenopathy, and creeping fat at laparotomy 5. Pathologic findings of transmural inflammation and/or epithelioid granulomas * Intestinal tuberculosis(at least one of the following is met) 1. Histologic evidence of caseating granulomas 2. Histologic demonstration of acid-fast bacilli 3. Growth of M. tuberculosis on tissue culture 4. Clinical, colonoscopic, radiologic, and/or operative evidence of Intestinal tuberculosis with proved tuberculosis elsewhere 5. Response to antituberculous therapy without subsequent recurrence in patients with clinical, colonoscopic, radiologic, and/or operative evidence of Intestinal tuberculosis

Exclusion criteria

* Refusal to participate in the study * Age: 15 years or younger * Comorbidity with acute infectious disease * Pregnancy * Previous history of medication including anti-TB drugs, immunosuppressive drugs, and chemotherapeutic agents\\ * Use of antibiotics within the previous three months

Design outcomes

Primary

MeasureTime frameDescription
Final diagnosis (Intestinal tuberculosis or Crohn's disease)6 months (In a subset of patients, for diagnosis of intestinal tuberculosis, final colonoscopic evaluation after completion of 6-months anti-tuberculous medication is needed)Patients with suspected diagnosis of intestinal tuberculosis or Crohn's disease will be invited to participate in this study. Study variables including past medical history, clinical symptoms and signs, laboratory variables, radiologic findings (Chest X-ray and small bowel follow-through, colonoscopic features) will be gathered at study enrollment. Final diagnosis of intestinal tuberculosis or Crohn's disease will be made according to the diagnostic criteria previously described (Lee YJ, et al. Endoscopy 2006;38:592-597). A prediction model using various variables for intestinal tuberculosis or Crohn's disease will be constructed in the development group and will be validated in the validation group.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026